Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel

Breast cancer is one of the most common and lethal cancers in women. As a hub gene involved in a diversity of tumors, the ubiquitin-conjugating enzyme H10 (UbcH10), may also play some roles in the genesis and development of breast cancer. In the current study, we found that the expression of UbcH10...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cheng, Pan, Yun-Hao, Shan, Ming, Xu, Ming, Bao, Jia-Lin, Zhao, Li-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394443/
https://www.ncbi.nlm.nih.gov/pubmed/25739083
http://dx.doi.org/10.3390/ijms16034698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394443/
https://www.ncbi.nlm.nih.gov/pubmed/25739083
http://dx.doi.org/10.3390/ijms16034698

Ejemplares similares